Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2019

01-01-2019 | Letter to the Editor

Association between red and processed meat with breast cancer: Comment on “Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies” by Guo et al.

Authors: Ran Xu, Jing Zhu

Published in: Breast Cancer Research and Treatment | Issue 1/2019

Login to get access

Excerpt

To the Editor, …
Literature
1.
Guo J, Wei W, Zhan L (2015) Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 151(1):191–198CrossRefPubMed
2.
Shannon J, Ray R, Wu C, Nelson Z, Gao D, Li W, Hu W, Lampe J, Horner N, Satia J et al (2005) Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiol Biomark Prev 14(1):81–90
Metadata
Title
Association between red and processed meat with breast cancer: Comment on “Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies” by Guo et al.
Authors
Ran Xu
Jing Zhu
Publication date
01-01-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4977-6

Other articles of this Issue 1/2019

Breast Cancer Research and Treatment 1/2019 Go to the issue

Epidemiology

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics

Clinical trial

Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer

Letter to the Editor

Regular exercise might be associated with higher skeletal muscle volume, favorable prognostic factor in breast cancer patients

Review

Comparative efficacy of adjuvant trastuzumab-containing chemotherapies for patients with early HER2-positive primary breast cancer: a network meta-analysis

Clinical trial

COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer

Preclinical study

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits